Miltenyi Biotec Acquires Owl Biomedical, Inc.

News   Apr 29, 2013

 
Miltenyi Biotec Acquires Owl Biomedical, Inc.
 
 
 
 

RELATED ARTICLES

Researchers Develop New Method to Generate Human Antibodies

News

Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.

READ MORE

Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine

News

The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.

READ MORE

Optofluidic Device Detects Tumour Cells in Blood

News

A team of researchers has patented a mobile device that can monitor cancer quickly, cheaply, effectively and non-invasively.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Microfluidics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE